Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Corcept Therapeutics Incorpora - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
CORT
Nasdaq
2834
https://www.corcept.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Corcept Therapeutics Incorpora
Why Is Theravance Bio (TBPH) Down 9% Since Last Earnings Report?
- Mar 27th, 2024 3:30 pm
Will Corcept (CORT) Bank on Korlym in 2024 Amid Stiff Rivalry?
- Mar 25th, 2024 2:20 pm
Why Is United Therapeutics (UTHR) Up 8.9% Since Last Earnings Report?
- Mar 22nd, 2024 3:30 pm
Corcept Therapeutics Full Year 2023 Earnings: Beats Expectations
- Feb 17th, 2024 1:18 pm
Corcept (CORT) Q4 Earnings Beat Estimates, Korlym Sales Grow
- Feb 16th, 2024 6:33 pm
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q4 2023 Earnings Call Transcript
- Feb 16th, 2024 2:04 pm
Q4 2023 Corcept Therapeutics Inc Earnings Call
- Feb 16th, 2024 1:57 pm
Corcept Therapeutics Inc Reports Significant Revenue Growth and Net Income Increase in Q4 and ...
- Feb 15th, 2024 9:44 pm
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update
- Feb 15th, 2024 9:07 pm
Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial
- Feb 15th, 2024 9:02 pm
Drug, Biotech Stock Q4 Earnings Due on Feb 15: ALNY, BPMC & More
- Feb 14th, 2024 3:12 pm
Jim Simons Bolsters Position in Corcept Therapeutics Inc
- Feb 14th, 2024 7:41 am
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results, Provide Corporate Update and Host Conference Call
- Feb 8th, 2024 9:05 pm
Will Corcept (CORT) Beat Estimates Again in Its Next Earnings Report?
- Jan 29th, 2024 5:10 pm
Corcept Appoints Roberto Vieira as President, Oncology
- Jan 29th, 2024 1:00 pm
Corcept (CORT) Stock Rises on Upbeat Revenue Guidance for 2024
- Jan 9th, 2024 3:48 pm
Corcept Therapeutics Provides Financial Update and Announces Stock Repurchase Program
- Jan 8th, 2024 1:00 pm
Corcept (CORT) Surges 5.1%: Is This an Indication of Further Gains?
- Jan 4th, 2024 2:04 pm
Corcept Therapeutics Stock Is Down 27%. It’s an ‘Ideal Buying Opportunity.’
- Jan 2nd, 2024 5:50 pm
Corcept (CORT) Falls on Loss of Korlym Patent Lawsuit to Teva
- Jan 2nd, 2024 4:27 pm
Scroll